• 한국유기농업학회지
• /
• 제19권4호
• /
• pp.553-563
• /
• 2011

This experiment was conducted to determine the effect of nattokinase (NK) additives on milk production and composition, and blood metabolites in dairy cows. The two kinds of nattokinase with high fibrinolytic activity were produced by two strains of bacteria, Bacillus amyloliquefacines (NK1) and Bacillus subtilis (NK2). Total fifteen Holstein cows (average $1.83{\pm}0.37$ parity; average milk yield $23.2{\pm}3.2$ kg/d) were randomly assigned to three treatments (5 animals per treatment). Cows were fed TMR supplemented with 0g, 100g and 100g for control, NK1 and NK2 treatment, respectively for 4 weeks. Milk yield was significantly higher (p<0.05) for NK1 (22.89 kg/d) than for control (21.07 kg/d) and NK2 (21.36 kg/d). Somatic cell counts in NK treatments were significantly lower than that in control group (58,000 vs. 21,000 and 35,000 cells/ml, control vs. NK1 and NK2). Serum ALT levels in all treatment were similar to the range of 32.00~35.83 IU/L, but AST levels in NK1 (85.67 IU/L) was significantly decreased compared with those in control and NK2 (121.67 and 117.67 IU/L respectively). Serum T-CHO levels in NK1 (145.33 mg/dl) was significantly decreased (p<0.05) compared with that in control (179.00 mg/dl) and NK2 (176.17 mg/dl). This finding showed that NK1 additives could possibly have a positive effect in lactation performance of mid-lactation dairy cows by increasing milk yield, reducing somatic cell count, improving liver function and decreasing cholesterol in blood.

• 한국식품과학회지
• /
• 제44권5호
• /
• pp.600-606
• /
• 2012

콩을 소재로한 전통 발효식품으로부터 혈전용해능이 뛰어난 균주를 분리하였으며, B. subtilis로 동정되었다. 따라서 이를 B. subtilis IDCC 9204(특허균주기탁: KCTC-11471 BP), 그 혈전용해 효소는 NK-IL9204로 명명하였다. B. subtilis IDCC 9204가 생산하는 고역가의 NK-IL9204를 단백질 분석법에 기초하여 분석한 결과, 분자량은 27.7 kDa의 homogenous enzyme으로 확인되었다. 또한 기존에 알려진 일본의 발효식품인 낫도 유래의 B. subtilis var. natto가 생산하는 nattokinase 와의 sequence 분석을 진행한 결과, 99.5% homology가 일치하는 serine protease계열의 nattokinase로 확인되었다. 그러나 NK-IL9204는 물리 화학적인 조건에서 B. subtilis var. natto가 생산하는 nattokinase와 다소 차이를 나타내었으며 본 실험에서는 B. subtilis var. natto가 생산하는 nattokinase보다 상대적으로 높은 열 안정성과 pH 안정성을 나타내었다. In vitro 실험에서 NK-IL9204는 최적 반응온도 $40^{\circ}C$, 열 안정성은 $90^{\circ}C$까지 효소활성을 유지하였으며, 최적 반응 pH는 pH 8로 알칼리-혈전용해효소의 특성을 나타내었으며, 약산성에서 강알칼리 영역까지 넓은 pH 구간 안정성을 갖는 것이 특징이다. NKIL9204의 in vivo에서의 효능과 생체 내 안정성을 동물실험을 통해 확인한 결과, 생체 내에서도 혈전용해효소의 활성이 소실되지 않고 유지되며, 혈전분해와 관련된 생체 내 인자들을 활성화시키는 역할을 하는 특징을 갖는다. NK-IL9204는 30,000 FU/g 이상의 고역가를 달성하여 산업적 측면에서 생산성도 확보함으로써 수입의존적 원료를 국산화할 수 있을 것으로 예상된다.

• Journal of Microbiology and Biotechnology
• /
• 제29권8호
• /
• pp.1281-1287
• /
• 2019

Nattokinase (NK, E.C. 3.4.21.62) is a serine protease produced by Bacillus subtilis natto that shows promise for the treatment of thrombotic disease. In this study, we assessed the effects of NK on the development of hepatocellular carcinoma (HCC), a principal malignancy of the liver that causes morbidity and mortality worldwide. Crude extracts of NK (NCE) were isolated from fermentation medium by centrifugation and separated into three fractions (<10 K, 100~30 K and >30K). Orthotopic HCC mouse models were established and NCE was administered by oral gavage. H&E staining was performed to examine the pathology of HCC livers. Immunohistochemistry and immunofluorescence were used to evaluate FOXM1, CD31, CD44 and vimentin expression in the liver. Compared to PBS groups, NCE increased the survival rates of HCC-bearing mice to 31% and decreased ascites. Low-intensity ultrasound imaging showed that the hypoechoic mass area was lower in NCE-treated mice and that tumor growth significantly decreased. IHC staining showed that the expression of FOXM1 was inhibited by NCE treatment. Immunofluorescence results revealed lower levels of CD31, CD44 and vimentin in the NCE groups. Taken together, these data demonstrate that NCE from Bacillus subtilis natto improves survival and inhibits tumor growth in HCC mice.